Technical420 Site Search

As we approach the mid-point of the year, we want to highlight some of the most significant themes in the cannabis industry that could prove to be important catalysts for the entire sector.  Going forward, we expect the market to be highly focused on these 7 themes and believe that…

After the market closed on Wednesday, Tilray, Inc. (TSX: TLRY) (Nasdaq: TLRY) filed a preliminary proxy statement with the United States (US) Securities and Exchange Commission (SEC) and we consider the filing to be significant. Two key proposals that were highlighted in the preliminary proxy statement are related to increasing…

Following the completion of a merger with Aphria, Tilray (TSX: TLRY) (Nasdaq: TLRY) has been frequently highlighted on major financial media platforms. We believe the combined company owns high-value, strategic cannabis assets in North America and the European Union (EU). Earlier this week, Tilray CEO Irwin Simon was featured on…

Tilray, Inc. (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced the launch of Symbios, a complement to the Company’s existing medical brand portfolio in Canada. This new brand was developed to provide a broader spectrum of formats and unique cannabinoid ratios at a…

Following Canopy Growth’s (TSX: WEED) (Nasdaq: CGC) weaker-than-expected earning’s report, the Canadian cannabis sector has been under pressure.  During the last year, we have noticed increasing interest in emerging international cannabis markets from Canadian Licensed Producers (LPs). From the European Union (EU) to North America (Mexico and the US), leading…

Today, the United States stock market is closed in honor of memorial day and we want to take this time to discuss how the cannabis industry has advanced since last year. From North and South America to the European Union (EU), the cannabis industry is becoming a burgeoning global market,…

Earlier this week, Tilray, Inc. (TLRY: TSX) (TLRY: Nasdaq) filed a few documents with the United States Securities and Exchange Commission (SEC) that reported a sale of more than 600,000 common shares. The stock sale is valued at more than $8.8 million and we find the transaction to be worth…

Last week, marked another milestone of the legal cannabis industry after Jazz Pharmaceuticals (Nasdaq: JAZZ) completed the acquisition of GW Pharmaceuticals plc., a leader in the science, development and commercialization of cannabinoid-based prescription medicines. Although the acquisition did receive as much attention as the merger between Aphria and Tilray, Inc. (TLRY.TO)…

Tilray, Inc. (TLRY: TSX) (TLRY: Nasdaq) tried to pull a fast one on the market and quietly reported quarterly financial results without a issuing a press release or holdings a conference call. After reading into the numbers, we are not surprised by Tilray’s decision to quietly announce its last quarterly…

Earlier this week, Tilray, Inc. (TLRY) (TLRY.TO) completed the merger with Aphria and created the world’s largest cannabis company (from a revenue standpoint).  We have been closely following the companies following the merger announcement in late 2020. After the deal was reported, both companies started to trend higher. Since then,…